Delia Deschaine joins Squire Patton Boggs

Delia Deschaine, previously Member at Epstein Becker & Green, has joined Squire Patton Boggs as Partner in the firm’s Corporate Practice. Delia focuses her practice on the healthcare and life sciences industries, representing pharmaceutical companies and biotechnology manufacturers on Food and Drug Administration (FDA) and Drug Enforcement Administration (DEA) regulatory matters, transactional matters and in related government investigations.